Close this search box.
Close this search box.

Industry Keynote: Sepsis Tech and Innovation

Breaking New Ground in Sepsis Diagnosis and Management with Non-Culture-Based Tests

The presentation discusses the current challenges in detecting sepsis-causing pathogens and how the use of non-culture-based-tests like T2Bacteria and T2Candida provide faster and more accurate results than the current standard of care, which relies on a positive blood culture.1

Speakers: Dr. Debra Goff, PharmD, FCCP, from The Ohio State University Wexner Medical Center and Dr. Aparna Ahuja, the Chief Medical Officer of T2 Biosystems

1. Nguyen, M. H., et al. Performance of the T2Bacteria Panel for Diagnosing Bloodstream Infections. A Diagnostic Accuracy Study. Annals of Internal Medicine. 2019.


T2 Biosystems
101 Hartwell Avenue
Lexington, MA 02421
Phone: 781-457-1200
Fax: 781-357-3080